Skip to main content

Animations

MJFF Publications

5231 - 5240 of 6516 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2023
  • 2013
  • 2024
  • 2024
  • 2023
  • Summary Details
    OPEN
    Title: Neither alpha-synuclein fibril strain nor host murine genotype influences seeding efficacy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00679-1
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Digital outcome measures from smartwatch data relate to non-motor features of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00719-w
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-63130-8
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Alpha-synuclein aggregates are phosphatase resistant
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-024-01785-0
    Citation Count: 7
  • Summary Details
    OPEN
    Title: A neurocomputational view of the effects of Parkinson’s disease on speech production
    Journal Name: Frontiers in Human Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3389/fnhum.2024.1383714
    Citation Count: 16
  • Summary Details
    OPEN
    Title: A blood-based marker of mitochondrial DNA damage in Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abo1557
    Citation Count: 77
  • Summary Details
    OPEN
    Title: LRRK2: an éminence grise of Wnt-mediated neurogenesis?
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2013.00082
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-024-01761-8
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Detecting the symptoms of Parkinson’s disease with non-standard video
    Journal Name: Journal of NeuroEngineering and Rehabilitation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12984-024-01362-5
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Interaction of an α-synuclein epitope with HLA-DRB1∗15:01 triggers enteric features in mice reminiscent of prodromal Parkinson’s disease
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuron.2023.07.015
    Citation Count: 47
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.